<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab2">
 <label>Table 2</label>
 <caption>
  <p>A selected examples of significant clinical trials.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th/>
    <th>Conditions</th>
    <th>Numbers of enrollment (estimated)</th>
    <th>Results</th>
    <th>Reference/trials</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Hydroxychloroquine</td>
    <td>Mild</td>
    <td>30</td>
    <td>Negative</td>
    <td>
     <sup>
      <xref ref-type="bibr" rid="CR39">39</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>Hydroxychloroquine</td>
    <td>Mild/severe</td>
    <td>62</td>
    <td>Positive</td>
    <td>
     <sup>
      <xref ref-type="bibr" rid="CR41">41</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>Hydroxychloroquine</td>
    <td>Symptomatic disease</td>
    <td>510</td>
    <td>Ongoing</td>
    <td>
     <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04332991" xmlns:xlink="http://www.w3.org/1999/xlink">https://clinicaltrials.gov/ct2/show/NCT04332991</ext-link>
    </td>
   </tr>
   <tr>
    <td>Hydroxychloroquine</td>
    <td>Prevention</td>
    <td>40,000</td>
    <td>Ongoing</td>
    <td>
     <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04303507" xmlns:xlink="http://www.w3.org/1999/xlink">https://clinicaltrials.gov/ct2/show/NCT04303507</ext-link>
    </td>
   </tr>
   <tr>
    <td>Lopinavir/ritonavir</td>
    <td>Severe</td>
    <td>199</td>
    <td>Negative</td>
    <td>
     <sup>
      <xref ref-type="bibr" rid="CR51">51</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>Remdesivir</td>
    <td>Mild/Moderate</td>
    <td>308</td>
    <td>Ongoing</td>
    <td>
     <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04252664" xmlns:xlink="http://www.w3.org/1999/xlink">https://clinicaltrials.gov/ct2/show/NCT04252664</ext-link>
    </td>
   </tr>
   <tr>
    <td>Remdesivir</td>
    <td>Severe</td>
    <td>453</td>
    <td>Negative</td>
    <td>
     <sup>
      <xref ref-type="bibr" rid="CR59">59</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>Remdesivir</td>
    <td>Severe</td>
    <td>2400</td>
    <td>Ongoing</td>
    <td>
     <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04292899" xmlns:xlink="http://www.w3.org/1999/xlink">https://clinicaltrials.gov/ct2/show/NCT04292899</ext-link>
    </td>
   </tr>
   <tr>
    <td>Remdesivir</td>
    <td>Moderate</td>
    <td>1600</td>
    <td>Ongoing</td>
    <td>
     <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04292730" xmlns:xlink="http://www.w3.org/1999/xlink">https://clinicaltrials.gov/ct2/show/NCT04292730</ext-link>
    </td>
   </tr>
   <tr>
    <td>Remdesivir</td>
    <td>Moderate/Severe</td>
    <td>800</td>
    <td>Ongoing</td>
    <td>
     <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04280705" xmlns:xlink="http://www.w3.org/1999/xlink">https://clinicaltrials.gov/ct2/show/NCT04280705</ext-link>
    </td>
   </tr>
   <tr>
    <td>Dexamethasone</td>
    <td>Severe</td>
    <td>200</td>
    <td>Ongoing</td>
    <td>
     <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04325061" xmlns:xlink="http://www.w3.org/1999/xlink">https://clinicaltrials.gov/ct2/show/NCT04325061</ext-link>
    </td>
   </tr>
   <tr>
    <td>Tocilizumab(IL-6 inhibitor)</td>
    <td>Severe</td>
    <td>20</td>
    <td>Positive</td>
    <td>
     <sup>
      <xref ref-type="bibr" rid="CR84">84</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>Tocilizumab</td>
    <td>Mild/Severe</td>
    <td>188</td>
    <td>Ongoing</td>
    <td>
     <ext-link ext-link-type="uri" xlink:href="http://www.chictr.org.cn/showprojen.aspx?proj=49409" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.chictr.org.cn/showprojen.aspx?proj=49409</ext-link>
    </td>
   </tr>
   <tr>
    <td>Anakinra (IL-1 inhibitor)</td>
    <td>Mild/Severe</td>
    <td>342</td>
    <td>Ongoing</td>
    <td>
     <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04330638" xmlns:xlink="http://www.w3.org/1999/xlink">https://clinicaltrials.gov/ct2/show/NCT04330638</ext-link>
    </td>
   </tr>
   <tr>
    <td>Baricitinib (JAK inhibitor)</td>
    <td>Mild</td>
    <td>80</td>
    <td>Ongoing</td>
    <td>
     <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04340232" xmlns:xlink="http://www.w3.org/1999/xlink">https://clinicaltrials.gov/ct2/show/NCT04340232</ext-link>
    </td>
   </tr>
   <tr>
    <td>Convalescent plasma</td>
    <td>Severe</td>
    <td>10</td>
    <td>Positive</td>
    <td>
     <sup>
      <xref ref-type="bibr" rid="CR63">63</xref>
     </sup>
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
